-
公开(公告)号:US20190002939A1
公开(公告)日:2019-01-03
申请号:US15777932
申请日:2016-04-15
申请人: Jiangnan University
发明人: Wanmeng MU , Bo JIANG , Shuhuai YU , Yingying ZHU , Tao ZHANG
CPC分类号: C12P19/12 , C12N9/1051 , C12N9/88 , C12P19/14 , C12P19/18 , C12Y204/01009 , C12Y402/02017 , C12Y402/02018
摘要: The invention discloses a high-efficiency synthesis method of difructose anhydride III. The method comprises the following steps: firstly converting sucrose into inulin by using inulosucrase without separating polysaccharide, and then converting inulin by using inulin fructotransferase to synthesize the functional disaccharide difructose anhydride III. The method has the advantages of simple process and high efficiency, and a conversion rate of synthesizing inulin into difructose anhydride III can reach 40%-54%. In order to obtain purer difructose anhydride III, yeast is utilized to remove small molecule monosaccharides in a reaction solution, and the finally obtained purer difructose anhydride III can be easily separated and purified. Thus, the method has broad market application prospects.
-
2.
公开(公告)号:US20180251748A1
公开(公告)日:2018-09-06
申请号:US15907340
申请日:2018-02-28
申请人: Jiangnan University
发明人: Tao ZHANG , Bo JIANG , Hangyu JIANG , Wanmeng MU , Ming MIAO
摘要: An arginine deiminase mutant with improved enzyme activity and temperature stability and application thereof were provided, belonging to the technical field of genetic engineering and enzyme engineering. The arginine deiminase mutant is proline, namely Gly292 Pro, mutated from glycine near an enzyme active center. A wild-type arginine deiminase arcA coding gene is molecularly modified by a site-directed mutation technique to obtain a mutant enzyme ADIG292P, which has glycine at position 292 of an amino acid sequence of the wild type arginine deiminase mutated to proline. The arginine deiminase, modified by site-directed mutation, of the present invention has 1.5 times of increase in enzyme activity and 5.43 times of increase in half-life period at 40° C. compared with the wild-type enzyme, which solves the problems of low catalytic ability and temperature stability during the catalytic synthesis of citrulline using arginine deiminase, and lays a foundation for industrial production of efficient synthesis of citrulline and medication application.
-
公开(公告)号:US20200109391A1
公开(公告)日:2020-04-09
申请号:US16718743
申请日:2019-12-18
申请人: Jiangnan University
发明人: Tao ZHANG , Bo JIANG , Hangyu JIANG , Wanmeng MU , Ming MIAO
摘要: An arginine deiminase mutant with improved enzyme activity and temperature stability and application thereof were provided, belonging to the technical field of genetic engineering and enzyme engineering. The arginine deiminase mutant is proline, namely Gly292 Pro, mutated from glycine near an enzyme active center. A wild-type arginine deiminase arcA coding gene is molecularly modified by a site-directed mutation technique to obtain a mutant enzyme ADIG292P, which has glycine at position 292 of an amino acid sequence of the wild type arginine deiminase mutated to proline. The arginine deiminase, modified by site-directed mutation, of the present invention has 1.5 times of increase in enzyme activity and 5.43 times of increase in half-life period at 40° C. compared with the wild-type enzyme, which solves the problems of low catalytic ability and temperature stability during the catalytic synthesis of citrulline using arginine deiminase, and lays a foundation for industrial production of efficient synthesis of citrulline and medication application.
-
公开(公告)号:US20190136219A1
公开(公告)日:2019-05-09
申请号:US16245881
申请日:2019-01-11
申请人: Jiangnan University
发明人: Tao ZHANG , Bo JIANG , Hangyu JIANG , Wanmeng MU , Ming MIAO
CPC分类号: C12N9/78 , C12N2800/101 , C12P13/10 , C12Q1/34 , C12Y305/03006
摘要: A genetically engineered arginine deiminase reconstructed by site-directed mutagenesis belongs to the technical field of genetic engineering technology. Its amino acid sequence is shown as SEQ ID No. 1. In the amino acid sequence of the arginine deiminase reconstructed by site-directed mutagenesis, glycine at position 264 is mutated to proline, compared to an amino acid sequence of native arginine deiminase. Compared with wild type enzyme, the effective pH range effect of the mutated arginine deiminase according to the present invention is broadened to a certain extent, and especially a good enzyme activity is achieved at physiological pH 7.4. With the broadening of the effective pH effect range, the mutant enzyme still has higher stability under the condition of pH 5.5-7.5. Therefore, the problem that the arginine deiminase generally is low in enzymatic activity and short in half-life in vivo under physiological conditions in clinical application for tumor therapy is solved, and a good condition for using the enzyme and an encoding gene thereof for clinical treatment is created.
-
-
-